Johnson & JohnsonJNJ

Johnson & Johnson (JNJ) is one of the world's largest healthcare companies, founded in 1886. After spinning off its consumer-health unit as Kenvue in 2023, JNJ now focuses on pharmaceuticals and medical devices. Carries one of the few AAA-rated balance sheets among US corporates and is a dividend aristocrat with 60+ years of consecutive increases. Listed on NYSE. Defensive — less cyclical than tech or consumer-discretionary names — but exposed to litigation risk (notably long-running talc cases) and US drug-pricing politics. Like any single stock, the price can move sharply on news. Diversify.